4//SEC Filing
Frapaise Francois-Xavier 4
Accession 0001142576-09-000027
CIK 0001142576other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:13 PM ET
Size
5.0 KB
Accession
0001142576-09-000027
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Other
Common Stock
2009-11-16$9.91/sh+1,412$13,994→ 1,412 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on November 16, 2009.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeother
Related Parties
1- filerCIK 0001455044
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:13 PM ET
- Size
- 5.0 KB